Late-Breaking Study Results of the HT Supreme™ Healing-Targeted DES Demonstrated Equivalent Outcomes with Exceptional Safety
SinoMed_admin2021-01-06T15:14:16+08:002020-11-17
About SinoMed_admin
This author has not yet filled in any details.So far SinoMed_admin has created 9 blog entries.
SINOMED Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme Coronary Drug-Eluting Stent
SinoMed_admin2020-07-14T12:22:28+08:002020-7-13
SINOMED was listed on the STAR Market of the Shanghai Stock Exchange
SinoMed_admin2020-11-13T10:45:47+08:002019-10-30